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ABSTRACT
Objective: The objective of this study is to develop a controlled release matrix tablet of candesartan cilexetil to reduce the frequency of administration, 
enhance bioavailability and improve patient compliance; a once daily sustained release formulation of candesartan cilexetil is desirable.
Methods: The prepared tablets from F1 to F24 were evaluated with different evaluation parameters like weight variation, drug content, friability, 
hardness, thickness and swelling ability. In vitro release for all formulas were studied depends on the type and amount of each polymer, i.e. (16 mg, 
32 mg and 48 mg) respectively beside to the combination effect of polymers on the release of the drug from the tablet.
Results: In vitro release showed that formula 13 had the faster release (100% after 4 h) which contained acacia (1:1) and the lowest sustain release 
was showed for F7 (73% after 8 h) which contained HPMC K100M (1:1). Formula 1 was an 89 % release after 8 h which contain eudragit RS100; F4 
was a 100 % release after 5 h which contain Na CMC, F10 was a 100% after 8 h which contain xanthan gum and F16 was a 100 % release after 5 h 
which contain tragacanth polymer. Formula 9 had a lower release than F7 and F8 respectively. Formula 7 can be used for sustain oral drug delivery of 
candesartan cilexetil while Formula 13 can be used in contrary as fast release tablets for faster response.
Conclusion: Controlled drug delivery system is promising for less dosing and higher patient compliance.
Keywords: Angiotensin II receptor antagonist, Hypertension, Matrix system, Control release.
INTRODUCTION
For many years, drugs were discovered and used clinically for different 
diseases, but until now, there is no drug meets all biopharmaceutical 
requirements. Drugs used for cardiovascular diseases (CVDs) 
were discovered and developed. One of the drugs used for CVDs is 
candesartan cilexetil. Candesartan cilexetil is selective angiotensin II 
receptor antagonist mainly on the AT1 sub type receptors. Candesartan 
cilexetil has poor oral bioavailability (<40%) and this due to first-
pass metabolism in the liver [1]. The half-life of the drug is about 9 
hrs and peak plasma concentration reaches after 4 hrs. Candesartan 
cilexetil solubility showed in spite of it present as a salt of weak acid 
practically insoluble in water and sparingly soluble in methanol. As oral 
bioavailability is low, frequent administration of the drug is intended 
to overcome the low bioavailability concerns. Frequent administration 
of drugs for long-term treatment for patients with chronic diseases 
such as hypertension is not desirable. Single dose administration in a 
day is one of the approaches to enhance patient compliance. Sustain 
release or controlled release tablet dosage form is one of the promising 
drug delivery systems used to decrease the frequency of the drug 
administration and to improve the bioavailability. Drugs with higher 
efficacy are prepared as controlled release tablets which are much 
better than conventional tablet dosage forms [2]. Extensive in vitro 
and in vivo studies of sustained release dosage forms are done to make 
it more safe and effective toward treatment of diseases. Matrix tablet 
is one of the approaches related to controlled release system. Matrix 
tablets must contain one or more polymer which controls or modulate 
the release of the drug from the tablet. Polymers are cross-linked with 
drug and the release mechanism depends on the type of the polymer 
used. Polymers are biodegradable, non-toxic, and safe like hydroxyl 
propyl methyl cellulose (HPMC) and xanthan gum [3].
Candesartan cilexetil was approved by FDA in September 2000 and 
presently marketed by AstraZeneca under the name “Atacand®.” Recent 
reports indicated its increase use, signifying its benefit in the treatment 
of stroke, heart failure, diabetic renal disease, and diabetic retinopathy. 
Being a highly lipophilic drug (Log P=6.1) with low aqueous solubility 
of 5×10−5 g/L, the drug is classified as a Class II drug according to the 
biopharmaceutical classification system [4].
A tablet is an important dosage form which considered the first 
preferable type for patient’s use. It comprises a mixture of active 
substances and excipients, usually in powder form, a compressed 
form of powder into a solid dose. Over the past 30 years or more, 
the development and complication involved in marketing new drug 
molecules have increased, with related focusing on the therapeutic 
benefits of sustained drug delivery [5].
From the wide choice of matrix forming materials which are important 
in the preparation of controlled release formulations are polyethylene 
oxides (PEO), methacrylic polymers, guar gum, xanthan gum, sodium 
alginate, chitosan, poly (acrylic acids), etc. Among the variety of 
hydrophilic polymers used, PEO is one of the most important polymers 
used in the preparation of the matrix tablets due to their non-toxic, 
high water-soluble, and swellable. Methacrylic polymers (Eudragit) 
also attracted researchers in preparation of controlled release dosage 
forms, due to their high chemical stability, compatible, cost-effective, 
and sustain effect on the drug release. Natural gums hydrate and swell 
upon contact with water, and these have been used for the preparation 
of controlled release dosage forms [6]. For controlled release dosage 
form containing the drug dispersed uniformly in hydrophilic or 
hydrophobic polymers, the release of the drug is controlled by diffusion 
of the drug, or by surface erosion of the polymer in the medium, or by 
combination of the two mechanisms.
HPMC is one of the polymers used for the preparation of oral 
controlled drug delivery systems also natural gums have been used 
for the preparation of matrix tablets. Xanthan gum is a high molecular 
weight hetero polysaccharide gum which produced by a pure culture 
fermentation of carbohydrates with the microorganism Xanthomonas 
campestris. Xanthan gum has been used in oral and topical formulations 
like in cosmetics and foods industry also as suspending agent [7].
Research Article
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2016.v9s3.14719
Asian J Pharm Clin Res, Vol 9, Suppl. 3, 2016, 161-170
 Salih and Nief 
162
Granulation is a technique used in the preparation of tablets, in which 
it involves particles enlargement by agglomeration. In the granulation 
process, fine particles are converted into larger agglomerates by 
different mechanisms to granules. In general, granulation is preferred 
after an initial mixing of the powder ingredients along with the drug, 
so a uniform distribution of each ingredient throughout the powder 
mixture is achieved. Granules used in the pharmaceutical industry are 
primarily produced as an intermediary with a size range of 0.2-0.5 mm 
which either packed as a dosage form or mixed with other excipients 
before tablet. The preferred less costly granulation technique is dry 
granulation which could be achieved either by slugging for small scale 
production and roller compaction for large-scale production [8]. The 
rationale of this study is to prepare candesartan cilexetil matrix tablets 
by dry granulation technique using different polymers. Natural and 
synthetic polymers will affect the properties of candesartan cilexetil 
matrix tablets, so these tablets were evaluated for different evaluation 
parameters also the sustain release effect was studied to overcome 




Candesartan cilexetil (Micro Labs, Bengaluru, India), Eudragit 
RS100 (HIMEDIA Laboratories, India), sodium carboxy methyl 
cellulose (NaCMC) (Sigma Chemical Co., USA), HPMC K100 (HIMEDIA 
Laboratories, India), xanthan gum (HIMEDIA Laboratories, India), acacia 
gum (Sigma-Aldrich Co., USA), Tragacanth (HIMEDIA Laboratories, 
India), talc (Afco., India), polyvinylpyrrolidone K30 (Riedel De Haen 
AG Seelze, Hannover, Germany), microcrystalline cellulose (Avecil® 
pH 102) (Sigma-Aldrich Co., USA), lactose (Riedel-deltaen, Germany), 
magnesium stearate (HIMEDIA Laboratories, India), disodium hydrogen 
orthophosphate, and potassium di hydrogen orthophosphate (SD Fine-
Chem Limited, Mumbai, India). All other chemicals and reagents used 
were of analytical grade.
Instruments
Tablet machine (Korsch EKO, Germany), manual hardness tester (Stokes, 
Monsanto Co. Ltd.), Vernier Calliper (model-Triclrbrand), Friabilator 
(Roche, Germany), ultraviolet (UV)-visible spectrophotometer (Carry 
win UV, Varian, Australia), Fourier transform infrared (FTIR) system 
(Shimadzu, Japan), pH meter (Hanna, Italy), FTIR System (FTIR-8400 
Shimadzu, Japan), differential scanning calorimetry (DSC) (Shimadzu, 
Japan), and X-ray diffractometry (Philips Analytical PW 3710). Other 
assistant laboratory materials and instruments used were considered 
official and registered.
Methods
Preparation of matrix tablets
The method used for the preparation of tablets was dry granulation 
technique by slugging. In general, drug and other components for 
each formula are mixed without magnesium stearate (lubricant) in 
bottles, and then after the mixing for 15 minutes, half of the lubricant 
(magnesium stearate) was added and the mixture compressed into one 
slug tablet by single punch tablet machine. Slug tablet then weighed 
and calculated the real number of tablets in which this number will 
help in determining the remaining amount of lubricant used. After 
calculating the required amount of lubricant to be used, the slug was 
sieved to granules by siever and the resulted granules were ready for 
the second compression by adding the calculated amount of lubricant 
to the granules and compressed to obtain the tablets [8,9].
Each tablet contained the drug in constant amounts for all formulas 
(16 mg), the polymers to be used for the study were (Eudragit RS100, 
NaCMC, HPMC K100, xanthan gum, acacia and tragacanth) in the ratio 
1:1, 1:2, and 1:3, and the other excipients were used in constant ratios 
for all formulas as shown in Table 1a.
Combination of two polymers (either natural or synthetic polymer 
combination) in the ratio 1:1:1 also prepared as shown in Table 1b.
Evaluation of the granules
Before compression step into tablets, the granules were evaluated for 
some evaluation properties such as angle of repose which done by 
funnel method, bulk density, tapped density, compressibility index (CI), 
and Hauser’s ratio as shown in Table 2 [10,11]. Tapped bulk density 
(TBD), loose bulk density (LBD), and CI were calculated by using the 
following equations:
TBD Weight of the powder
Final volume
=  (1)




Carr s compressibility index TBD LBD
TBD








Hausner s ratio TBD
LBD
 =  (4)
Evaluation of tablets
The prepared tablets were evaluated for weight variation, drug content, 
friability, hardness, and thickness as shown in Table 3, swelling index as 
shown in Table 4 and Fig. 1 and in vitro dissolution test [11].
Weight variation
20 tablets were randomly selected from each formula (F1 to F24), and 
the average weight of these tablets was measured. According to the 
United State Pharmacopeia (USP), not more than 2 of individual weights 
of tablets were out of the average by more than the percentage deviation 
and none deviate twice the percentage. The official limit of percentage 
deviation in this study is 7.5% because the total weight of the tablet is 
150 mg which lies in the range between 130 and 324 mg [11,12].
Drug content
The amount of candesartan cilexetil in each tablet for each formula was 
measured using a UV spectrophotometer. The tablet was dissolved in 
small volume of methanol and then suitable dilution of the methanol in 
volumetric flasks using a buffer (pH 6.8) and read the solution at 255 nm 
which is the wave length of candesartan cilexetil [13]. The amount of 
candesartan cilexetil was measured from the recorded absorbance 
that obtained from the spectrophotometer, and the concentration of 
the dug in solution was measured from the equation obtained from the 
calibration curve in 6.8 buffer solution.
Friability, hardness, and thickness
Random 20 tablets were taken for evaluation from each formula. 
According to the USP, the accepted value must be <1%. Friability 
measured using Roche friabilator (25 rpm for 4 minutes). The friability 









10 tablets were taken randomly for hardness test from each formula. 
The hardness was measured using Monsanto® manual hardness tester, 
and the average value for the tablets was measured [14].
Five tablets from each formula were taken randomly, and the 
average thickness of the tablets was calculated using Vernier caliper 
scale [12,14].
Determination of swelling index
The swelling behavior of matrix tablets was determined at 37±0.5°C 
in phosphate buffer (pH 6.8). Three tablets from each formula were 
individually kept in a glass Petri dish which containing 50 ml of the 
Asian J Pharm Clin Res, Vol 9, Suppl. 3, 2016, 161-170
 Salih and Nief 
163
buffer solution. The weight of individual tablet was taken before the 
swelling study (M0). The tablet was kept in a basket. The weight of a 
tablet was taken at time intervals of 2, 4, 6, and 8 hrs, and at the end 
of this time, the tablet was removed, polished with a tissue paper, and 
weighed again (Mt) [15].
Percent hydration (swelling index) was calculated as shown in Fig. 1 







= ×  (6)
Table 1a: Preparation of different formulas of matrix tablets containing one polymer with different ratios
Ingredients (mg) F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 F13 F14 F15 F16 F17 F18
Candesartan 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16
Eudragit RS 100 16 32 48 - - - - - - - - - - - - - - -
Sodium CMC - - - 16 32 48 - - - - - - - - - - - -
HPMC K 100 - - - - - - 16 32 48 - - - - - - - - -
Xanthan gum - - - - - - - - - 16 32 48 - - - - - -
Acacia gum - - - - - - - - - - - - 16 32 48 - - -
Tragacanth - - - - - - - - - - - - - - - 16 32 48
Talc 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9 9
PVP K 30 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16
MCC 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16 16
Lactose 72 56 40 72 56 40 72 56 40 72 56 40 72 56 40 72 56 40
Mg stearate 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5
Total weight 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150 150
CMC: Carboxy methyl cellulose, HPMC: Hydroxyl propyl methyl cellulose, PVP: Polyvinylpyrrolidone
Table 2: Evaluation of the granules
Formula Angle of repose 
(Ө°)






Type of flow Hausner’s ratio
F1 32±1.7 Good 0.39±0.031 0.44±0.021 11±0.01 Good 1.12±0.1
F2 30±1.2 Excellent 0.44±0.042 0.51±0.011 13.7±0.02 Good 1.15±0.23
F3 31±1.1 Good 0.45±0.024 0.53±0.041 15±0.01 Good 1.17±0.15
F4 34±1.6 Good 0.38±0.017 0.46±0.033 17±0.02 Fair 1.21±0.3
F5 38±1.2 Fair 0.47±0.039 0.56±0.025 16±0.02 Fair 1.19±0.2
F6 35±1.8 Good 0.48±0.023 0.54±0.017 11.1±0.03 Good 1.29±0.13
F7 31±1.3 Good 0.33±0.038 0.37±0.041 10.8±0.02 Excellent 1.27±0.42
F8 33±1.1 Good 0.51±0.034 0.59±0.014 13.5±0.01 Good 1.27±0.1
F9 35±1.2 Good 0.55±0.031 0.67±0.029 18±0.02 Fair 1.22±0.19
F10 33±1.5 Good 0.43±0.031 0.50±0.033 14±0.04 Good 1.4±0.2
F11 36±1.3 Fair 0.46±0.021 0.52±0.021 11.5±0.03 Good 1.28±0.21
F12 32±1.5 Good 0.47±0.032 0.58±0.034 19±0.02 Fair 1.23±0.1
F13 34±1.9 Good 0.57±0.03 0.72±0.04 20.8±0.03 Fair 1.26±0.3
F14 33±1.1 Good 0.33±0.024 0.39±0.012 15.3±0.01 Good 1.48±0.1
F15 38±2 Fair 0.54±0.012 0.62±0.031 12.9±0.02 Good 1.36±0.5
F16 37±1.1 Fair 0.41±0.014 0.49±0.045 16.3±0.04 Fair 1.29±0.3
F17 35±1.3 Good 0.32±0.025 0.39±0.021 17.9±0.03 Fair 1.5±0.2
F18 31±1.5 Good 0.4±0.012 0.46±0.015 13±0.03 Good 1.32±0.3
F19 36±1.4 Fair 0.3±0.023 0.37±0.026 18.9±0.02 Fair 1.36±0.29
F20 34±1.1 Good 0.33±0.02 0.4±0.021 17.5±0.03 Fair 1.39±0.3
F21 35±2.2 Good 0.5±0.014 0.59±0.032 15.2±0.03 Good 1.3±0.4
F22 37±2.4 Fair 0.43±0.029 0.49±0.05 12.2±0.02 Good 1.32±0.2
F23 36±1.9 Fair 0.35±0.034 0.40±0.019 12.5±0.03 Good 1.34±0.5
F24 39±1.6 Fair 0.4±0.036 0.45±0.032 11.1±0.02 Good 1.3±0.1
Table 1b: Preparation of different formulas of matrix tablets containing combination of two polymers with 1:1 ratio
Ingredients (mg) F19 F20 F21 F22 F23 F24
Candesartan 16 16 16 16 16 16
Eudragit RS 100 16 16 - - - -
Sodium CMC 16 - 16 -
HPMC K 100 - 16 16 - - -
Xanthan gum - - - 16 16 -
Acacia gum - - - 16 - 16
Tragacanth - - - - 16 16
Talc 9 9 9 9 9 9
PVP K 30 16 16 16 16 16 16
MCC 16 16 16 16 16 16
Lactose 72 56 40 72 56 40
Mg stearate 5 5 5 5 5 5
Total weight 150 150 150 150 150 150
MCC: Microcrystalline cellulose, CMC: Carboxy methyl cellulose, HPMC: Hydroxyl propyl methyl cellulose, PVP: Polyvinylpyrrolidone
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Where, Mt and M0 are the weight of tablet at time=t and time=0, 
respectively.
In vitro drug dissolution
In vitro dissolution of candesartan cilexetil was carried out using 
dissolution apparatus Type II (paddle type), in which the paddle speed 
was at 50 rpm and using 900 ml buffer solution (pH 6.8) at 37°C. The 
procedure last 8 hrs long (n=8) depends on the polymer type and/or 
concentration used of the polymer and how it will affect the release 
profile of the drug from the formulas (F1 to F24). Samples (10 ml) 
were withdrawn every 1 hr and replaced with the same amount of 
fresh buffer (pH 6.8) to maintain sink condition, and these samples 
were collected and the absorbance values of the drug from those 
samples were measured using UV-visible spectroscopy at 255 nm and 
then determine the amount of drug in each sample using the equation 
obtained from the calibration curve [5].
6-kinetics of drug release profile
The cumulative amounts of candesartan cilexetil released from a tablet 
from different formulas were fitted to four models which are zero order 
kinetics, first order kinetics, Higuchi model, and Korsmeyer-Peppas 
model. These models were used to determine the mechanism of drug 
release [12].
Statistical analysis
The one-way analysis of variance test was used to determine the 
significance of difference among the results obtained from the studied 
formulations. The level of significance was set at (α 0.05), in which less 
than this value was considered to be statistically significant and more 
than this was considered statistically insignificant.
RESULTS
Evaluation of granules for all formulas (F1 to F24) was done and 
the results showed in Table 2. Angle of repose for each formula was 
measured, and results showed excellent and good flow for all the 
formulas except formulas (F5, F11, F15, F16, F19, F22, F23, and F24), 
these formulas showed fair flow.
CI which was calculated by equation 3 showed most of the formulas 
was having good compressibility except for formulas (F4, F5, F9, F12, 
F13, F16, F17, F19, and F20) which they were showed fair CI. Results 
showed that Hausner ratio values were of <1.25 indicates a good flow 
of granules, whereas >1.5 indicates poor flow, in which Hausner ratio is 
a measure of the interparticulate friction. Lower CI or lower Hausner 
ratios of granules indicates better flow properties than higher values 
as shown in Table 2.
Results for the evaluation of tablets were shown in Table 3; weight 
variation study was considered within the accepted range as stated by 
the USP for all the formulas.
Table 3: Evaluation parameters of the tablets
Formulation Weight 
mg±SD (n=20)








F1 149.4±1.1 99±0.1 0.3 3.2±0.1 4.2±0.01
F2 149.7±1.2 99.2±0.2 0.35 4.4±0.2 4.7±0.01
F3 148.1±1.4 100±0.11 0.22 3.5±0.2 4.2±0.03
F4 149.2±1.7 98.5±0.1 0.32 3.7±0.1 4.2±0.02
F5 148.8±1.9 99.7±0.2 0.51 4.5±0.2 4.1±0.014
F6 151±1.8 99.4±0.1 0.44 5.3±0.3 3.9±0.01
F7 150±1.3 98.7±0.4 0.5 6.1±0.4 4.1±0.013
F8 149.2±2.3 100±0.1 0.7 3.5±0.3 4.4±0.012
F9 149.5±1.1 100.1±0.1 0.65 4.1±0.2 4.3±0.03
F10 150±2.5 99.9±0.2 0.15 3.9±0.31 4.4±0.01
F11 148.3±1.1 99.2±0.2 0.3 4.9±0.2 4.1±0.04
F12 151.7±1.9 99.1±0.1 0.42 6.4±0.24 4.2±0.037
F13 149.8±1.4 99.8±0.12 0.18 4.6±0.1 4.9±0.01
F14 149.9±2.8 98.4±0.2 0.45 5.4±0.4 4.5±0.02
F15 150±1.9 100.4±0.17 0.53 3.9±0.1 4.1±0.015
F16 148.9±1.8 99.1±0.12 0.21 5.1±0.37 5.1±0.054
F17 149.3±2.5 101.4±0.1 0.33 6.8±0.2 4.7±0.037
F18 151.1±1.4 100.9±0.23 0.65 4.9±0.32 4.9±0.02
F19 150.2±2.3 99.7±0.1 0.27 5.1±0.21 3.9±0.018
F20 149.7±1.8 98.2±0.1 0.36 4.4±0.3 4.4±0.03
F21 149.9±1.1 100.3±0.14 0.17 6.2±0.27 4.2±0.01
F22 149.8±1.3 99.9±0.2 0.44 4.8±0.15 4.8±0.035
F23 149.9±1.7 99.1±0.11 0.38 4.9±0.17 5.2±0.02
F24 150.1±2.1 99.8±0.16 0.46 6.2±0.12 4.2±0.037
SD: Standard deviation




HCL medium pH (1.2) 0.0099±0.0006
Buffer medium pH (6.8) 0.029±0.004
HCL medium (pH 1.2) with 0.35% polysorbate 20 0.093±0.008





SD from mean (n=3). PEG: Poly ethylene glycol
Fig. 1: Swelling index histogram for the prepared formulas every 
2 hrs interval
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Drug content measurements were within the accepted values. Friability 
measurements were accepted for all formulas because the values 
obtained were <1% as stated by the USP. Hardness values were within 
the range of sustained or controlled release tablet type. Thickness 
values showed acceptable properties and complied with pharmacopeia 
specifications [12].
The results of the swelling behavior are shown in Fig. 1. The swelling 
index indicates the ability of polymer to absorb water from dissolution 
media and swells. The water absorption and swelling of the tablets 
started slowly and continued during the time of the experiment. The 
time was set for 8 h and the tablet weighed every 2 hrs.
Samples (10 ml) were taken every 1 hr, and the absorbance was 
measured by UV spectroscopy. Each absorbance value was used to 
calculate the concentration the drug release at the predetermined time. 
The collected results were done in triplicate (n=3).
Polymers used in different amounts either as a single polymer or in a 
combination of two polymers. From F1 to F18 in which single polymer 
was used in each formula, the release of candesartan cilexetil was 
affected by the type of the polymer and the amount of the polymer used, 
whereas from F19 to F24, in which combination of two polymers were 
used (synthetic or natural), the drug release affected by both polymers 
from the matrix tablet.
Six polymers were primarily used for preparation of matrix tablets, in 
which they were Eudragit RS100, HPMC K100M, NaCMC, xanthan gum, 
acacia gum, and tragacanth.
Formulas (F1, F4, F7, F10, F13, and F16) contain single polymer, in 
which they were eudragit RS100, NaCMC, HPMC K100M, xanthan gum, 
acacia gum, and tragacanth, respectively. All these formulas had the 
same amount of drug in each tablet (16 mg), i.e., (1:1) ratio to the drug.
The effect of the type of polymer on the release profile of candesartan 
cilexetil was shown in Fig. 2. F13 had faster release (100% after 4 hrs) 
which contained acacia gum and the slowest release was showed 
for F7 (73% after 8 hrs) which contained HPMC K100M. From these 
results, F7 was considered the most sustain release formula and used 
for further evaluation-like IR, DSC, and X-ray diffraction.
F1 was an 89% release after 8 hrs which contains eudragit RS100; F4 
was a 100% release after 5 hrs which contains NaCMC; F10 was a 100% 
after 8 hrs which contains xanthan gum; F16 was a 100% release after 
5 hrs which contains tragacanth polymer as shown in Fig. 2.
Each polymer used in three different amounts (16, 32, and 48 mg) for 
preparation of matrix tablets. The effect of the amount of polymer used 
on the release profile of candesartan cilexetil was shown in Figs. 3-8, 
respectively. As shown in Fig. 3, the use of eudragit RS100 in different 
amounts as shown in F1, F2, and F3, respectively, the release was 
retarded and sustained from the tablet when the amount of polymer 
in the tablet was increased in respect to the amount of the drug. F9 had 
a slower release (*p<0.05) than F7 and F8, respectively, as shown in 
Fig. 5. These results indicated that increase in the amount of polymer 
in the tablet will provide more gelation of the tablet, and this will, in 
turn, lead to retardation in the release of the drug from the system. This 
effect was observed with the use of other polymers, in which the release 
of drug from matrix tablet retarded by increase the polymer to drug 
ratio [14].
A combination of two different polymers in ratio (1:1) also studied. The 
combination was selected according to the source of the polymer used 
so in case of F19, F20, and F21, the polymer combination used was of 
synthetic source, whereas F22, F23, and F24 the polymer combination 
used was of natural source.
The release of the drug was retarded from all the formulas (*p<0.05) 
as shown in Fig. 9, and this due to the effect of the polymers, in which 
Fig. 2: In-vitro dissolution for studying the effect of type of 
polymer on the release profile of candesartan cilexetil in 
6.8 buffer solution (F1 contain eudragit RS100, F4 contain NaCMC, 
F7 contain HPMC K100M, F10 xanthan gum, F13 contain acacia 
and F16 contain tragacanth)
Fig. 3: In vitro dissolution for studying the effect of amount of 
polymer on the in vitro release profile of candesartan cilexetil 
from matrix tablets contain eudragit RS100 polymer in 6.8 buffer 
(F1: 16 mg eudragit, F2: 32 mg eudragit and F3: 48 mg eudragit)
more than one mechanism of release would involve in the release of 
drug substances such as swelling, pH dependent, and floating [7].
The IR spectra of pure drug candesartan cilexetil show characteristic 
absorption peaks as shown in Table 5 and Fig. 10. These peaks were 
presented in the IR scan of the matrix tablet; the most sustain formula 
which consists of candesartan cilexetil and HPMC K100M (F7) was used 
for IR study.
DSC thermogram showed a sharp characteristic endothermic peak of 
candesartan cilexetil around its melting point as shown in Fig. 11; such 
peak indicates that candesartan cilexetil used is in the pure crystalline 
state.
DSC thermogram for F7 which contains candesartan cilexetil 
and HPMC K100M showed a characteristic endothermic peak of 
candesartan cilexetil. This peak corresponding to the drug melting 
which was appeared with small shifting and reduce the intensity 
which indicated that the drug is still in the crystal form as shown in 
Fig. 12 [13].
The X-ray diffraction pattern of candesartan cilexetil indicates that 
the drug present in crystal form due to the presence of sharp peaks as 
shown in Fig. 13, whereas in F7, the X-ray diffraction indicated that most 
characteristic peaks shown by pure candesartan cilexetil were absent, 
and others were appearing with the markedly reduced intensity as 
shown in Fig. 14. These observed peaks indicated that drug crystalline 
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structure remained unchanged after the physical mixing of components 
and tablet compression [13].
The in vitro release study for the formulas (F1, F4, F7, F10, F13, and 
F16) was applied to four kinetic models, in which they are zero order, 
first order, and Higuchi and Korsmeyer-Peppas models. The mechanism 
of drug release for candesartan cilexetil was determined by measuring 
the rate constant, the high correlation coefficient (R2), and the best-
fitted line as shown in Table 6.
DISCUSSION
Differences in angle of repose were due to different reasons the 
important one is the amount of lubricant used. Magnesium stearate 
is used as lubricant in small amount. It is a cohesive material and so 
will help in decrease the powder dust during the filling and so will 
enhance granules flowability. Larger amount of lubricant may decrease 
the flowability of the granules [17]. Good lubricated granules will show 
good flow properties in comparing to less lubricated granules. Angle of 
repose test showed that the θ values increased when the concentration 
of lubricant was from 0% to 0.25%, but increasing the concentration 
up to 1.5%, it remained constant, so this gave indication that the 
flow improved with low amounts of lubricant after which there was 
no change [17]. CI related to the granular bridge strength and to the 
stability of the bridges, as the strength increase the CI became good 
to excellent [18]. Swelling of the polymer matrix will lead to delay 
the release of candesartan cilexetil from the tablet due to increase in 
diffusion path length. The swelling index depends the type of polymer 
used in which the results showed that the polymers used in the study 
could be arranged according to the ability to absorb water from the 
buffer solution from the higher to the lower degree of swelling as 
follows HPMC K100M > NaCMC > xanthan gum > acacia > tragacanth > 
eudragit RS100. From these results, the higher swelling was obtained in 
the formulas containing HPMC K100M and this due to the hydrophilicity 
of the polymer. While the hydrophobic polymer eudragit RS100 showed 
the lower swelling capacity [6].
The mechanism of swelling was initiated with polymer being swollen, 
and then, a viscous gel layer was formed, and at this point, the drug 
started to release slowly forms the matrix system [6,19]. In vitro 
dissolution studies in buffer media pH 6.8, results showed that the 
release of the drug from the matrix system affected by different factors 
such as the amount of polymer used in each formula, the type of the 
polymer used if it is hydrophilic or hydrophobic, and the source of the 
polymer if it was natural or synthetic polymer.
The saturation solubility of candesartan cilexetil was the main factor 
affecting the dissolution of the drug from the dissolution media. 
Fig. 4: In vitro dissolution for studying the effect of amount of 
polymer on the in vitro release profile of candesartan cilexetil 
from matrix tablets contain NaCMC polymer in 6.8 buffer 
(F4: 16 mg NaCMC, F5: 32 mg NaCMC and F6: 48 mg NaCMC)
Fig. 5: In vitro dissolution for studying the effect of amount of 
polymer on the in vitro release profile of candesartan cilexetil 
from matrix tablets contain HPMC K100M polymer in 6.8 buffer 
(F7: 16 mg HPMC K100M, F8: 32 mg HPMC K100M and F9: 48 mg 
HPMC K100M)
Fig. 6: In vitro dissolution for studying the effect of amount of 
polymer on the in vitro release profile of candesartan cilexetil 
from matrix tablets contain xanthan gum polymer in 6.8 buffer 
(F10: 16 mg xanthan gum, F11: 32 mg xanthan gum and 
F12: 48 mg xanthan gum)
Fig. 7: In vitro dissolution for studying the effect of amount of 
polymer on the in vitro release profile of candesartan cilexetil 
from matrix tablets contain acacia gum polymer in 6.8 buffer 
(F13: 16 mg acacia, F14: 32 mg acacia and F15: 48 mg acacia)
Fig. 8: In vitro dissolution for studying the effect of amount of 
polymer on the in vitro release profile of candesartan cilexetil from 
matrix tablets contain tragacanth polymer in 6.8 buffer (F16: 16 mg 
tragacanth, F17: 32 mg tragacanth and F18: 48 mg tragacanth)
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Different studies showed that the drug was practically insoluble in 
buffer solution pH 6.8 and so surfactant must be used to increase the 
solubility and to achieve sink condition. The solubility of the drug was 
differing from solvent to other and the choice of solvent is depend on 
the purpose of the study. The solubility of the drug in various solvents 
was given in Table 4 [13]. The order of increasing solubility as follows: 
Poly ethylene glycol (PEG) 400 > PEG 200 > PG > phosphate buffer 
(pH 6.8) with 0.35% polysorbate 20 > glycerin > HCL solution (pH 1.2) 
with 0.35% polysorbate 20 > phosphate buffer (pH 6.8) > HCL solution 
(pH 1.2). The high solubility of candesartan cilexetil in PEG 400 is due 
to the longer non-polar chain of PEG 400 as the longest non-polar chain 
reflects the hydrophobic interactions of the drug with the liquid-vehicle 
molecule [20].
Increase in the pH of the medium resulted in an increase in the 
solubility of candesartan cilexetil; this is due to candesartan cilexetil is 
an acidic drug molecule also the use of polysorbate 20 as a surfactant 
increase the solubility of candesartan cilexetil in both HCL and buffer 
media. These results showed in Table 4 [21,22]. The solubility of 
candesartan was very slightly soluble in buffer solution (pH 6.8) 
and so Tween 20 (polysorbate 20) which is safe and non-toxic with 
concentration (0.35% w/w) was used to increase solubility of the drug 
in the dissolution media [2,23].
Mechanism of dissolution if it was swelling, pH dependent, and floating 
was affected greatly by the type of the polymer used [24].
Table 5: Characteristic IR peaks of candesartan cilexetil
Functional group Characteristic peaks of candesartan 
cilexetil observed in IR region (cm−1)






Fig. 9: In vitro dissolution for studying the effect of combination of 
two polymers (1:1) on the in vitro release profile of candesartan 
cilexetil from matrix tablets
Fig. 10: Fourier transform infrared spectra of pure powder of candesartan cilexetil [29]
Fig. 11: FT-IR spectra of candesartan cilexetil and HPMC K100 physical mixture (1:1)
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nature of NaCMC lead to rapid drug dissolution, diffusion, and 
relatively fast erosion of matrix systems, and this is because of the 
presence of ionized carboxylic acid groups in the polymer structure. 
These ionized carboxylic acid groups lead to an increase in the rate 
and amount of water uptake by ion-pair repulsion mechanism. Break 
of the bonds was responsible for the gel structure is due to stretch in 
the gel network [27].
The disordered random coil conformation of xanthan gum polymer 
loses its ability to form a gel structure while the ordered elongated 
conformation is able to form gel structure. The formation of an ordered 
structure in xanthan gum polymer will increase with increasing 
concentration of added salt. The presence of salt in the medium will 
cause the transition temperature (Tm) to increase. In addition, the 
hydrodynamic volume of this polymer will change with changing in 
the ionic strength due to changes in the intramolecular electrostatic 
repulsion by the ions. Furthermore, the viscosity of xanthan gum 
affected by the ionic strength of the medium. All these properties will 
reflect the viscosity and gelation properties of the polymer and so affect 
the release time of the drug from the matrix system [14].
Tragacanth gum forms a weak gel once dissolved in water. The 
quality of crosslinking of the polymer is not as high as the chemical 
crosslinking. This property may be used for drugs having controlled 
release properties. The release mechanism from the matrix system 
of tragacanth polymer is by gelling of the polymer by water or buffer 
solution this will lead to form a less porous structure so tend the drug 
to will release [28].
IR study showed that presence of undisturbed candesartan cilexetil in 
the tablet. The IR spectra of the drug solubilized in various excipients 
were similar to that of the pure drug chromatograms, so there were 
no drug-excipients interactions as shown in Fig. 15 [29]. The data 
obtained from a dissolution study of the formulations were analyzed 
using various mathematical models as reported in DDSolver which is 
a specialized, freely available software program developed by Zhang 
et al. to provide a tool for facilitating the parameter calculations 
in dissolution data analysis using nonlinear optimization model-
dependent approaches [30].
The highest correlation coefficient (R2) was resulted with Korsmeyer-
Peppas model combined with zero order in case of F1, F7, and F10, which 
indicates that the drug release is ruled by both diffusions of the drug 
and dissolution/erosion of the tablet matrix. While F4, F13, and F16, 
the highest correlation coefficient (R2) was resulted with Korsmeyer-
Peppas model combined with Higuchi model. Korsmeyer-Peppas model 
showed that the drug release kinetics is the most fitting because the 
values of the diffusion exponent (n) were between 0.484 and 1.039. 
The formulations (F1, F4, F7, F10, F13, and F16) were followed non-
Fickian diffusion kinetics, in which the diffusion exponent (n) values 
were >0.5. These results indicate that the release mechanism of the 
drug was shifted from diffusion controlled to an anomalous transport 
(non-Fickian), in which both the diffusion and the erosion mechanisms 
were controlling the release [12,31].
Table 6: Correlation coefficients of different mathematical models for selected formulations
Formula code Zero order First order Higuchi model Korsmeyer–Peppas model
k0 R2 k1 R2 kH R2 kKp R2 n
F1 10.892 0.9893 0.170 0.9113 25.500 0.8188 11.410 0.9880 0.974
F4 23.600 0.3505 0.591 0.9563 46.094 0.9892 46.996 0.9867 0.484
F7 8.659 0.9925 0.120 0.9387 20.184 0.7967 8.070 0.9921 1.039
F10 13.672 0.9504 0.261 0.9226 32.339 0.8757 19.367 0.9770 0.806
F13 28.300 0.6746 0.645 0.9484 49.573 0.9764 45.619 0.9881 0.581
F16 22.467 0.7333 0.493 0.9519 43.475 0.9788 38.730 0.9979 0.594
Fig. 12: DSC thermogram of pure candesartan cilexetil
Fig. 13: DSC thermogram of candesartan cilexetil and HPMC 
K100M physical mixture (1:1)
The pH of the dissolution media affects the release of candesartan 
cilexetil from HPMC matrix system in spite of the polymer hydration 
and gelling not affected by change in the pH of the medium. The higher 
binding capacity of HPMC K100M to drug leads to more sustained effect 
than other polymers [25].
The hydrophilicity of acacia gum made the matrix system of the 
tablet releases the drug in a gradient manner in short time than other 
polymers. Acacia had gel forming mechanism in which it swells rapidly 
in contact with gastric fluid and maintains the shape integrity and bulk 
density less than the gastric content [26].
Eudragit RS 100 was in granular form and it used more widely than 
any other polymers, in which it is pH-independent swelling polymer 
with good mucoadhesive properties [26]. Eudragit RS 100 sustains 
the release of candesartan cilexetil from the matrix system by floating 
mechanism.
Fast release (100% in 5 hrs) was obtained from matrix tablets 
containing NaCMC polymer. High aqueous solubility and hygroscopic 
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CONCLUSION
Matrix tablet dosage form is one of the promising drug delivery systems 
for controlling the release of drug and to decrease the frequency of 
administration. F7 which contains HPMC K100M showed most sustain 
release for candesartan cilexetil than other studied polymers due 
to the higher binding and swelling of the polymer. HPMC K100M is 
hydrophilic polymer which absorbs water from dissolution media more 
than other polymers so, F7 can be used for sustain oral drug delivery 
of candesartan cilexetil. F13 in contrary which contains acacia gum 
showed faster release of the drug due to lower gelation than other 
polymers so F13 can be used as fast release tablets for faster response.
Controlled drug delivery system is promising for less dosing and 
higher patient compliance. Dry granulation method is good approach 
for enhancing flowability of poorly flowable powders and give other 
benefit which is enhance the binding of the tablet excipients and so 
higher harness will obtained than direct compression method.
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Fig. 15: X-Ray diffraction of candesartan cilexetil and HPMC 
K100M physical mixture (1:1)
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